Aspalatone
Based on 1 Customer Validation
Aspalatone is an orally active antiplatelet aggregant with IC50 of 180 μM. Aspalatone has antioxidant and neuroprotective activities.
For research use only. We do not sell to patients.
- Purity : 98.40%
- CAS No.: 147249-33-0
- Formula: C15H12O6
- Molecular Weight:288.25
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-123133
PKSI-527Plasma Kallikrein Inhibitor -
HY-125798
2,3-Dehydro-2-deoxy-N-acetylneuraminic acidNeuraminidase Inhibitor -
HY-W017851
4-Phenyl-2-pyrrolidinoneDrug Precursor and Intermediate -
HY-155126
LZWL02003Anti-Neuroinflammatory Agent -
HY-W002108
3,4-Dihydroquinolin-2(1H)-oneBuilding Block -
HY-W012906
L-AllylglycineGABA Receptor Antagonist -
HY-139167
7-HydroxywarfarinAnticoagulant Agent -
HY-N0666S2
DL-Aspartic acid-d3Stable Isotope -
HY-W016194
1-(Carboxymethyl)cyclohexanecarboxylic acidSuccinic Acid -
HY-W741611
Dehydro WarfarinMetabolite -
HY-139012
RC574GPx1 Activator
Biological Activity
Description
Chemical Information
-
CAS No. 147249-33-0
-
Appearance Solid
-
Molecular Weight 288.25
-
Formula C15H12O6
-
Color White to off-white
-
SMILES
O=C(C1=C(OC(C)=O)C=CC=C1)OC2=C(C)OC=CC2=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Han BH, et al. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity. Arzneimittelforschung. 1994 Oct;44(10):1122-6. [Content Brief]
[2]. Kim HC, et al. Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat. Life Sci. 1997;61(24):PL 373-81. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Aspalatone Related Classifications
HY-118072 Related Classifications
Powered by Bioz